In addition, HBP1 protein level in HBV positive (HBs Ag+) hepatoma patients was lower than that in HBV negative (HBs Ag−) hepatoma patients (Fig. 1 c). This evidence concerns the gene HBP1 and hepatocellular carcinoma.